| Financial Year |
March 31 2023 |
| Monetary Funds |
361,649,891.35 |
| Held-for-trading Financial Assets |
58,745,736.98 |
| Notes Receivable |
44,418,279.85 |
| Accounts Receivable |
318,492,758.60 |
| Advances to Suppliers |
22,896,965.63 |
| Other Receivables |
29,547,884.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
206,159,167.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
70,000,000.00 |
| Other Current Assets |
23,950,482.44 |
| Total Current Assets |
1,167,034,395.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
410,223,307.66 |
| Under-construction Projects |
95,834,229.54 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
71,617,148.03 |
| R&D expenses |
-- |
| Goodwill |
184,892,971.52 |
| Long-Term Deferred and Prepaid Expenses |
38,789,025.88 |
| Deferred Income Tax Assets |
12,207,822.79 |
| Other Non-Current Assets |
197,500,404.32 |
| Sub-Total of Non-Current Assets |
1,240,489,834.19 |
| Total Assets |
2,407,524,229.34 |
| Short-Term Loans |
110,342,930.80 |
| Trading Financial liabilities |
3,160,085.40 |
| Notes Payable |
54,055,894.81 |
| Accounts Payable |
180,504,005.07 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
28,976,056.79 |
| Taxes Payable |
6,101,402.45 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
404,268,290.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
31,850,578.99 |
| Other Current Liabilities |
13,267,464.09 |
| Sub-Total of Current Liabilities |
841,746,647.43 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
47,863.30 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
183,831,340.99 |
| Total Liabilities |
1,025,577,988.42 |
| Paid-In Capital(Or Share Stock) |
151,359,994.00 |
| Capital Surplus |
704,497,437.28 |
| Surplus Reserve |
44,364,196.95 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
473,148,974.80 |
| Minority Stockholder's Interest |
8,799,867.14 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,373,146,373.78 |
| Owner's Equity（Stockholder's Equity） |
1,381,946,240.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,407,524,229.34 |
